A new injectable filler is making a splash for being minimally invasive and for the source that fills its vials: donated human fat from cadavers. The eerie origins of the shots have led to a mixed response. Some praise the innovations; others worry about future complications.
Tiger Aesthetics’ new product, AlloClae, has become popular with “patients eager to look their best in the boardroom” without “undergoing general anesthesia or taking days off for recovery,” said Business Insider. Rather than using an implant or a patient’s body fat to add volume to hips or augment breasts, AlloClae relies on “donor fat from a cadaver as a first-of-its-kind body filler.” On social media, influencers sometimes refer to buttocks injections of AlloClae as “zombie BBLs”, “zombie filler” and “corpse cosmetics”.
The rise in GLP-1 use has contributed to the trend, along with “filler fatigue”, as traditional fillers can “cause problems such as puffiness and lymphatic issues”, said The Guardian’s Ask Ugly column. People who are on Ozempic or are dieting heavily are “really thin and don’t have enough fat to transfer”, plastic surgeon Melissa Doft said. They want their “legs and their belly to be skinny but want their breasts to be fuller”.
Some are worried that fears about the origins of AlloClae could have a negative impact on organ donation. If people start “restricting their participation” due to fears of the product being used for cosmetic purposes, the “harm may outweigh the good”, Ryan Pferdehirt, the vice president of ethics services at the Center for Practical Bioethics, said to The Guardian. We need “skin grafts, bone marrow transplants and organ donation.” That is “far more important, I think, than the cosmetic aspects.”
|